Medical Device | January 06, 2022
Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
He has over 22 years of experience in pharmaceutical sales & business development
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
This is Enzene Biosciences third biosimilar to be approved
CDSCO to fast-track trials and approval for COVID19 vaccine
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
Financial support is being provided as a grant from the Government of India
Subscribe To Our Newsletter & Stay Updated
